DANVILLE, PA. – With the nation collectively spending about $18 billion per year on osteoporosis related bone fractures, Geisinger researchers found that streamlining the ordering process for osteoporosis bone density scans quadrupled the number of patients who received the exam.
An estimated 10 million Americans suffer from osteoporosis. Like most providers, Geisinger Health System measures the mineral content in the bones of patients who are at high-risk for osteoporosis through DXA scans.
Follow-up exams are usually needed to assess how the disease has progressed. Geisinger’s rheumatology department removed some of the steps involved, shifted the responsibility of ordering the exam from the patient’s primary care provider to the rheumatology staff and made greater use of Geisinger’s $80 million Electronic Health Record.
Before the change, 18% of patients received the test. After the test, 88% received the scan.
“A broken bone from osteoporosis can be excruciating and hard to recover from,” said Eric Newman, MD, Geisinger’s Rheumatology Director. “Testing for osteoporosis is the first step in preventing these breaks.”
Results of the study were presented at the American College of Rheumatology’s annual meeting in Boston recently. Geisinger had four presentations at the meeting, the most ever for the department.
The other work included:
Among the study’s key findings was that 94% of the patients received disease modifying antirheumatic drugs, which ease pain, reduce inflammation and reduce or prevent joint damage. This was far higher than anticipated, Newman noted.
While more than 3,000 study abstracts were submitted for the meeting, this was one of just 14 studies that were accepted as plenary presentations.
“It was an outstanding year for us,” Newman said. “These studies reflect our staff’s talent and commitment to delivering the best care to our patients.”
The studies were conducted by rheumatology fellows Leena Adhikesavan MD and Mark Diehl DO, primary care physician Nancy Gilhooley MD, staff rheumatologists Thomas Olenginski, MD and Androniki Bili, MD, MPH, fellowship director Thomas Harrington MD and Newman.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.